Lamotribene Ratiopharm Gmbh

Lamotrigine, the active ingredient in Lamotribene Ratiopharm Gmbh, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control partial seizures, generalized tonic‑clonic seizures, and to stabilize mood in bipolar disorder. It is indicated for adult and pediatric patients and is available across the European market under strict manufacturing controls.

GNH USA supplies Lamotribene Ratiopharm Gmbh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with adherence to stringent quality standards and regulatory requirements.

Lamotrigine is used to treat seizure disorders and mood instability, targeting neuronal excitability. - Partial seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Bipolar disorder: provides mood stabilization and reduces recurrence of depressive and manic episodes.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Dizziness - Headache - Nausea - Rash Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as agranulocytosis - Severe liver injury

When prescribing lamotrigine, several precautions should be observed to minimize risks. - Dose titration: increase gradually to reduce the risk of skin reactions. - Monitor blood counts: periodic CBC is recommended, especially during early therapy. - Avoid abrupt discontinuation: sudden stop may precipitate seizure recurrence. - Use caution in hepatic impairment: dose adjustment may be required. - Pregnancy: risk category unknown; discuss benefits and risks with a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase adverse effects. Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising toxicity risk. - Carbamazepine: significantly reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine levels, may require dose increase. - Oral contraceptives: increase lamotrigine clearance, possibly reducing therapeutic effect. Moderate Interactions (Monitor Closely): - Serotonergic agents (e.g., SSRIs, SNRIs): monitor for serotonin syndrome. - Other antiepileptic drugs: combined use may necessitate dose adjustments. - Antidepressants: observe for additive central nervous system depression.